Investment Rating - The investment rating for the company is "Buy" [1][6] Core Views - The report highlights that the company achieved excellent performance in Q1 2025, demonstrating its investment value even in adverse conditions [1][6] - The company reported a total revenue of 1068.54 billion yuan in Q1 2025, a year-on-year decrease of 4.14% but a quarter-on-quarter increase of 13.09% [1] - The net profit attributable to shareholders was 365.63 billion yuan, down 7.95% year-on-year but up 71.84% quarter-on-quarter [1] Summary by Sections Financial Performance - In Q1 2025, the company achieved a net profit of 365.63 billion yuan, with a basic earnings per share (EPS) of 0.77 yuan, reflecting a year-on-year decrease of 8.33% but a quarter-on-quarter increase of 75.00% [1] - The company's revenue and net profit figures indicate resilience despite a challenging market environment [1][6] Production and Output - The company produced 145.5 million barrels of oil liquids in Q1 2025, representing a year-on-year increase of 3.41% and a quarter-on-quarter increase of 0.62% [3] - Natural gas production reached 2530 billion cubic feet, up 10.24% year-on-year and 8.63% quarter-on-quarter, primarily due to contributions from specific projects [3] Pricing and Costs - The average oil price realized by the company was 72.65 USD per barrel, down 6.10% year-on-year but up 2.57 USD per barrel quarter-on-quarter [4] - The company maintained a low oil cost of 27.03 USD per barrel, which is a decrease from the previous year, indicating effective cost management [4] Capital Expenditure and Future Outlook - The company reported capital expenditures of 27.7 billion yuan in Q1 2025, with a stable budget for 2025 set between 1250-1350 billion yuan [5] - Profit forecasts for 2025-2027 indicate a net profit of 1364.41 billion yuan in 2025, with expected growth rates of -1.1%, 4.3%, and 5.3% for the following years [5][6]

长按即可参与 风险提示：本文所提到的观点仅代表个人的意见，所涉及标的不作推荐，据此买卖，风险自负。 作者： KAIZEN投资之道 来源：雪球 今天我们谈谈牧原股份 、 恒瑞医药 、 爱尔眼科 。 在投资的世界里 ， 寻找那些拥有核心竞争 力 、 深筑护城河的企业 ， 就如同在茫茫大海中寻找珍贵的珍珠 。 它们不仅能在市场的风浪中 稳稳当当 ， 更能随着时间推移 ， 散发出愈发夺目的光彩 。 2025年一季报的发布 ， 让牧原股份 、 恒瑞医药和爱尔眼科再次成为大家关注的焦点 。 它们各 自代表了生猪养殖 、 创新药和眼科医疗领域的顶尖水平 ， 不仅展现了强劲的业绩 ， 更透露出 未来增长的无限可能 。 接下来的分析 ， 将带你深入探寻这些企业背后的核心竞争力与护城河 ， 以及它们在投资价值上的对比和未来的市场潜力 。 一 、 牧原股份 ： 周期上行+成本优势 ， 生猪养殖龙头护城河稳固 1.2025年一季报业绩 ： 营业总收入360.61亿元 ， 同比增37.26% ； 净利润46.19亿元 ， 同 比增287.87% ； 归母净利润44.91亿元 ， 上年同期亏损23.79亿元 。 2.核心竞争力与护城河 ...

Core Insights - The article highlights the professional expertise and passion of Ge Lan from China Europe Fund, which has garnered trust from numerous investors and revitalized the industry [1] Group 1: Professional Background - Ge Lan's professional competence stems from her solid academic background and rigorous research approach, having studied at Tsinghua University and Northwestern University, which provided her with a strong foundation in science and technology [3] - Her scientific training equips her with strong logical thinking and insight into the essence of matters, forming a solid base for her investment career [3] - In her investment research, she employs scientific methods for in-depth analysis of investment targets, covering macroeconomic assessments, industry trends, and detailed company fundamentals [3] Group 2: Industry Engagement - Ge Lan's dedication to the photovoltaic industry is exemplified by her proactive approach in gathering firsthand information through extensive data analysis, phone surveys, and grassroots investigations across the country [3] - She engages directly with factory workers and industry experts to understand production operations and technological developments, allowing her to identify turning points in the industry [3] Group 3: Passion for the Pharmaceutical Sector - Ge Lan's passion for the pharmaceutical industry is driven by her respect for life and attention to healthcare development, viewing it as a critical sector for human health and well-being [4] - In 2017, she identified a pharmaceutical company with a market value of around 4 to 5 billion, which, despite its small size, demonstrated strategic foresight and strong R&D capabilities, leading her to hold onto the investment even during challenging market conditions [4] Group 4: Investment Philosophy - Ge Lan emphasizes the importance of innovation and social responsibility in her investment decisions, focusing not only on financial metrics but also on the potential for companies to create value in difficult times [4] - As a fund manager, she is aware that her investment choices can influence the market, thus she directs funds towards innovative and promising companies to promote industry transformation [4] Group 5: Future Outlook - Looking ahead, Ge Lan aims to continue leveraging her expertise and passion to discover more investment opportunities, providing surprises for investors with her keen insights and rigorous research approach [5]